Page 150 - MEMORIA_SEHH-FEHH_2023
P. 150
MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GETCC
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
• Multi-component cord blood banking: a proof-of-concept international exercise.
Transfus. 2023;21(6):526-37. doi: 10.2450/BloodTransfus.492.
Samarkanova D, Codinach M, Montemurro T, Mykhailova L, Tancredi G, Gallerano P, Ma-
llis P, Michalopoulos E, Wynn L, Calvo J, Pello OM, Gontica I, Rebulla P, Querol S.
Grupo cooperativo coautor: MultiCord12 Study Group.
• Optimized reagents for immunopotency assays on mesenchymal stromal cells for
clinical use.
Immunol Res. 2023;71(5):725-34. doi: 10.1007/s12026-023-09385-1.
Torrents S, Del Moral AE, Codinach M, Rodríguez L, Querol S, Vives J.
• Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vac-
cine: An Approach to Select Best Therapeutic Strategies.
Biomedicines. 2023;11(2):238. doi: 10.3390/biomedicines11020238.
Mejías Sosa L, López-Janeiro Á, Córdoba Iturriagagoitia A, Sala P, Solans BP, Hato L,
Inogés S, López-Díaz de Cerio A, Guillén-Grima F, Espinós J, De La Cruz S, Lozano MD,
Idoate MA, Santisteban M.
• Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-
directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma
(CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol. 2023;24(8):913-24. doi: 10.1016/S1470-2045(23)00222-X.
Oliver-Caldés A, González-Calle V, Cabañas V, Español-Rego M, Rodríguez-Otero P, Re-
guera JL, López-Corral L, Martín-Antonio B, Zabaleta A, Inogés S, Varea S, Rosiñol L,
López-Díaz de Cerio A, Tovar N, Jiménez R, López-Parra M, Rodríguez-Lobato LG, Sán-
chez-Salinas A, Olesti E, Calvo-Orteu M, Delgado J, Pérez-Simón JA, Paiva B, Prósper F,
Sáez-Peñataro J, Juan M, Moraleda JM, Mateos MV, Pascal M, Urbano-Ispizua A, Fernán-
dez de Larrea C.
• Optimization of universal allogeneic CAR-T cells combining CRISPR and transpo-
son-based technologies for treatment of acute myeloid leukemia.
Front Immunol. 2023 ;14:1270843. doi: 10.3389/fimmu.2023.1270843.
Calviño C, Ceballos C, Alfonso A, Jáuregui P, Calleja-Cervantes ME, San Martín-Uriz P,
Rodríguez-Márquez P, Martín-Mallo A, Iglesias E, Abizanda G, Rodríguez-Díaz S, Martínez-
Turrillas R, Illarramendi J, Viguria MC, Redondo M, Rifón J, Villar S, Lasarte JJ, Inoges S,
López-Díaz de Cerio A, Hernáez M, Prósper F, Rodríguez-Madoz JR.
150

